DeKALB – The Northwestern Medicine Kishwaukee Hospital Cancer Center is now offering an advanced tool for diagnosing recurrent prostate cancer that is typically only found in much larger, academic medical centers.
Axumin is a diagnostic agent for positron emission tomography (PET) imaging. The injectable agent can identify recurrences of cancer throughout the body in men who have previously been treated for prostate cancer. According to Dr. Alan Wan, medical oncologist, Northwestern Medicine Kishwaukee Hospital Cancer Center, recurrent disease typically is detected by a rise in PSA levels but often the location and extent cannot be detected by conventional imaging.
“For men with prostate cancer, this is a more accurate surveillance tool to help detect progression of the disease,” Wan said in a news release.”
According to the American Cancer Society, about one man in seven will be diagnosed with prostate cancer during his lifetime. The risk of prostate cancer increases with age, however, family history and other factors can increase risk in younger men.
Northwestern Medicine Kishwaukee Hospital Cancer Center has locations in DeKalb, Sandwich and Rochelle. For information, visit kishcancer.org or nm.org.